Results 161 to 170 of about 98,340 (384)

Harvesting AAV by tangential flow filtration using reverse asymmetric membranes

open access: yesBiotechnology Progress, EarlyView.
Abstract Efficient bioreactor clarification for harvesting virus particles is often challenging. Tangential flow filtration is attractive as it can be easily adapted for batch and perfusion operations. Here the feasibility of using reverse asymmetric hollow fiber membranes, where the more open support structure faces the feed stream, has been ...
Xiaolei Hao   +5 more
wiley   +1 more source

Prompting Fab Yeast Surface Display Efficiency by ER Retention and Molecular Chaperon Co-expression. [PDF]

open access: yes, 2019
For antibody discovery and engineering, yeast surface display (YSD) of antigen-binding fragments (Fabs) and coupled fluorescence activated cell sorting (FACS) provide intact paratopic conformations and quantitative analysis at the monoclonal level, and ...
Ge, Xin   +7 more
core  

Enhancing rapid Protein A performance in monoclonal antibody processing: Anion exchange chromatographic clarification

open access: yesBiotechnology Progress, EarlyView.
Abstract Clarification fidelity, including reduction of insoluble and soluble contaminants, has been demonstrated to significantly affect the performance and robustness of the Protein A capture chromatography step during the purification of monoclonal antibodies (mAb) and their derivatives expressed in CHO cell cultures.
Andrew Vail   +3 more
wiley   +1 more source

A questionnaire-based study on industrial waste management in Indian biopharmaceutical industries

open access: yesEnvironment Conservation Journal
This study investigates industrial waste management practices within the Indian biopharmaceutical sector through a questionnaire-based approach. The questionnaire, distributed among ten Indian biopharmaceutical industries (Himachal Pradesh (30°57'26.3"
Ishika Pringle   +2 more
doaj   +1 more source

Opportunities for Improving the Drug Development Process: Results from a Survey of Industry and the FDA [PDF]

open access: yes
In the United States, the Food and Drug Administration (FDA) agency is responsible for regulating the safety and efficacy of biopharmaceutical drug products. Furthermore, the FDA is tasked with speeding new medical innovations to market.
Adrian H. B. Gottschalk   +2 more
core  

Optimizing clarification processes in biopharmaceutical manufacturing through quality by design: Strategies, implications, and future prospects

open access: yesBiotechnology Progress, EarlyView.
Abstract Biopharmaceutical manufacturing processes in which the product of interest is extracellularly expressed typically employ a clarification step following cell culture or fermentation. During clarification, crude cell culture fluid or fermentation broth is processed to remove insoluble solids, cells, debris, and other particulates, with the ...
Kyeong‐won Yeop   +7 more
wiley   +1 more source

Practical considerations for optimal designs in clinical dose finding studies [PDF]

open access: yes
Determining an adequate dose level for a drug and, more broadly, characterizing its dose response relationship, are key objectives in the clinical development of any medicinal drug. If the dose is set too high, safety and tolerability problems are likely
Bretz, Frank   +2 more
core  

Transgenic Crops [PDF]

open access: yes, 2006
Transgenic Crops describes the basics of genetic modification for agricultural purposes and a brief history of the technology and the governing policies surrounding it.
Jeff Schahczenski, Katherine Adam
core  

Home - About - Disclaimer - Privacy